| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
| Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
| Farnesyl pyrophosphate synthase | 0 | 4 | 0 | 4 |
| Acetylcholinesterase | 0 | 4 | 0 | 4 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 2 | 0 | 2 |
| Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
| Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 14 | 0 | 0 | 14 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| thioredoxin reductase | 18 | 0 | 0 | 18 |
| phosphopantetheinyl transferase | 10 | 0 | 0 | 10 |
| NFKB1 protein, partial | 2 | 0 | 0 | 2 |
| GLS protein | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
| alpha-galactosidase | 3 | 0 | 0 | 3 |
| euchromatic histone-lysine N-methyltransferase 2 | 25 | 0 | 0 | 25 |
| cytochrome P450 2C19 precursor | 6 | 0 | 0 | 6 |
| chromobox protein homolog 1 | 16 | 0 | 0 | 16 |
| flap endonuclease 1 | 6 | 0 | 0 | 6 |
| DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
| muscarinic acetylcholine receptor M1 | 11 | 0 | 0 | 11 |
| lethal factor (plasmid) | 5 | 0 | 0 | 5 |
| Cytochrome P450 3A4 | 0 | 5 | 0 | 8 |
| Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| ATP-dependent phosphofructokinase | 13 | 0 | 0 | 13 |
| vitamin D3 receptor isoform VDRA | 8 | 0 | 0 | 8 |
| peripheral myelin protein 22 | 11 | 0 | 0 | 11 |
| ATP-binding cassette sub-family C member 3 | 0 | 19 | 0 | 19 |
| Multidrug resistance-associated protein 4 | 0 | 20 | 0 | 22 |
| Bile salt export pump | 0 | 26 | 0 | 26 |
| Translocator protein | 0 | 0 | 1 | 1 |
| Vasopressin V2 receptor | 0 | 4 | 3 | 8 |
| Oxytocin receptor | 0 | 3 | 4 | 7 |
| Vasopressin V1a receptor | 0 | 1 | 2 | 3 |
| Vasopressin V1a receptor | 0 | 4 | 3 | 7 |
| Vasopressin V1b receptor | 0 | 3 | 3 | 6 |
| Vasopressin V2 receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1b receptor | 0 | 2 | 1 | 4 |
| Translocator protein | 0 | 2 | 0 | 3 |
| Oxytocin receptor | 0 | 2 | 0 | 2 |
| Vasopressin V2 receptor | 0 | 3 | 2 | 5 |
| Canalicular multispecific organic anion transporter 1 | 0 | 20 | 0 | 21 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 11 | 0 | 0 | 11 |
| Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
| aldehyde dehydrogenase 1 family, member A1 | 14 | 0 | 0 | 14 |
| arylsulfatase A | 7 | 0 | 0 | 7 |
| Bloom syndrome protein isoform 1 | 9 | 0 | 0 | 9 |
| lamin isoform A-delta10 | 21 | 0 | 0 | 21 |
| Metabotropic glutamate receptor 6 | 0 | 1 | 2 | 4 |
| Excitatory amino acid transporter 4 | 0 | 2 | 0 | 2 |
| Glutamate transporter homolog | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 8 |
| Carbonic anhydrase 2 | 0 | 4 | 1 | 9 |
| N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 1 | 6 |
| Excitatory amino acid transporter 1 | 0 | 3 | 0 | 4 |
| Excitatory amino acid transporter 2 | 0 | 3 | 0 | 4 |
| Excitatory amino acid transporter 3 | 0 | 3 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 3 | 1 | 6 |
| Metabotropic glutamate receptor 1 | 0 | 1 | 2 | 4 |
| Metabotropic glutamate receptor 2 | 0 | 1 | 2 | 4 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 3 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 3 | 1 | 6 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 3 | 1 | 6 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| Chain A, Protein kinase C, iota | 0 | 1 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
| USP1 protein, partial | 11 | 0 | 0 | 11 |
| TDP1 protein | 25 | 0 | 0 | 25 |
| Microtubule-associated protein tau | 8 | 0 | 0 | 8 |
| regulator of G-protein signaling 4 | 11 | 0 | 0 | 11 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| mitogen-activated protein kinase 1 | 5 | 0 | 0 | 5 |
| survival motor neuron protein isoform d | 8 | 0 | 0 | 8 |
| cytochrome P450 3A4 isoform 1 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit pi | 8 | 3 | 1 | 12 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
| G1/S-specific cyclin-E2 | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 2 | 1 | 3 |
| Protein kinase C beta type | 0 | 2 | 2 | 4 |
| Cyclin-dependent kinase 1 | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 2 | 3 |
| Cyclin-dependent kinase 4 | 0 | 1 | 1 | 2 |
| G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 8 | 3 | 1 | 12 |
| Lethal factor | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 2 | 2 | 4 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 1 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 8 | 3 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 8 | 3 | 1 | 12 |
| Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 8 | 3 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 8 | 3 | 1 | 12 |
| cAMP-dependent protein kinase catalytic subunit gamma | 0 | 1 | 1 | 2 |
| cAMP-dependent protein kinase catalytic subunit beta | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 8 | 3 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 8 | 3 | 1 | 12 |
| G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 1 | 1 | 2 |
| G1/S-specific cyclin-E1 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 1 | 2 | 3 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 8 | 3 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 8 | 3 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 8 | 3 | 1 | 12 |
| Protein kinase C iota type | 0 | 1 | 2 | 3 |
| Histamine H2 receptor | 4 | 0 | 0 | 4 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 1 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 8 | 3 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 8 | 3 | 1 | 12 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 8 | 3 | 1 | 12 |
| MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 2 | 1 | 3 |
| Protein kinase C theta type | 0 | 1 | 2 | 3 |
| Protein kinase C zeta type | 0 | 1 | 2 | 3 |
| Protein kinase C delta type | 0 | 2 | 2 | 4 |
| Peroxisome proliferator-activated receptor alpha | 0 | 1 | 1 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 8 | 0 | 8 |
| NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
| G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
| GABA theta subunit | 8 | 3 | 1 | 12 |
| NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase LMTK3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 8 | 3 | 1 | 12 |
| Genome polyprotein | 0 | 1 | 1 | 2 |
| dopamine D1 receptor | 4 | 0 | 0 | 4 |
| ATAD5 protein, partial | 7 | 0 | 0 | 7 |
| Fumarate hydratase | 5 | 0 | 0 | 5 |
| AR protein | 28 | 0 | 0 | 28 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 14 | 0 | 0 | 14 |
| glucocorticoid receptor [Homo sapiens] | 24 | 0 | 0 | 24 |
| pregnane X nuclear receptor | 22 | 0 | 0 | 22 |
| estrogen nuclear receptor alpha | 28 | 0 | 0 | 28 |
| G | 8 | 0 | 0 | 8 |
| polyprotein | 5 | 0 | 0 | 5 |
| peroxisome proliferator activated receptor gamma | 15 | 0 | 0 | 15 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 16 | 0 | 0 | 16 |
| D(1A) dopamine receptor | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform 2 | 16 | 0 | 0 | 16 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 6 | 0 | 0 | 6 |
| 5-hydroxytryptamine receptor 4 | 0 | 8 | 1 | 9 |
| Interferon beta | 10 | 0 | 0 | 10 |
| HLA class I histocompatibility antigen, B alpha chain | 8 | 0 | 0 | 8 |
| Cellular tumor antigen p53 | 18 | 0 | 0 | 18 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 3 | 1 | 6 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 12 | 1 | 13 |
| D(2) dopamine receptor | 0 | 8 | 2 | 11 |
| Androgen receptor | 0 | 8 | 0 | 8 |
| Alpha-2B adrenergic receptor | 0 | 8 | 1 | 9 |
| Alpha-2C adrenergic receptor | 0 | 8 | 1 | 9 |
| D | 0 | 5 | 0 | 6 |
| D(3) dopamine receptor | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 1A | 0 | 6 | 0 | 6 |
| Alpha-2B adrenergic receptor | 0 | 4 | 0 | 4 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 4 |
| Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-2A adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-1D adrenergic receptor | 0 | 8 | 1 | 9 |
| D(1B) dopamine receptor | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 2A | 0 | 8 | 1 | 9 |
| 5-hydroxytryptamine receptor 2C | 0 | 8 | 1 | 9 |
| 5-hydroxytryptamine receptor 1B | 0 | 6 | 0 | 6 |
| D(4) dopamine receptor | 0 | 5 | 0 | 5 |
| D(3) dopamine receptor | 0 | 10 | 1 | 13 |
| Alpha-synuclein | 1 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 8 | 0 | 8 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 8 | 1 | 10 |
| Inositol hexakisphosphate kinase 1 | 8 | 0 | 0 | 8 |
| ATPase family AAA domain-containing protein 5 | 10 | 0 | 0 | 10 |
| Ataxin-2 | 12 | 0 | 0 | 12 |
| cytochrome P450 2C9, partial | 8 | 0 | 0 | 8 |
| Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 6 | 0 | 0 | 6 |
| geminin | 20 | 0 | 0 | 20 |
| Vitamin D-binding protein | 0 | 0 | 1 | 1 |
| Cytochrome P450 1A2 | 0 | 3 | 0 | 4 |
| Androgen receptor | 0 | 4 | 0 | 4 |
| Cytochrome P450 2D6 | 0 | 6 | 0 | 6 |
| Vitamin D3 receptor | 0 | 1 | 2 | 4 |
| Cytochrome P450 2C9 | 0 | 5 | 0 | 6 |
| Vitamin D3 receptor | 0 | 1 | 1 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 4 | 4 |
| Cytochrome P450 2C19 | 0 | 4 | 0 | 4 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 2 | 0 | 2 |
| Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
| acetylcholinesterase | 10 | 0 | 0 | 10 |
| RAR-related orphan receptor gamma | 21 | 0 | 0 | 21 |
| retinoic acid nuclear receptor alpha variant 1 | 18 | 0 | 0 | 18 |
| estrogen-related nuclear receptor alpha | 21 | 0 | 0 | 21 |
| IDH1 | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform a | 5 | 0 | 0 | 5 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
| Vpr | 2 | 0 | 0 | 2 |
| Bile salt export pump | 0 | 5 | 0 | 5 |
| Albumin | 0 | 0 | 2 | 2 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
| Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 4 |
| Cytochrome P450 2J2 | 0 | 4 | 0 | 4 |
| Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
| Frizzled-8 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 14 | 0 | 0 | 14 |
| cytochrome P450 2D6 | 8 | 0 | 0 | 8 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 20 | 0 | 0 | 20 |
| DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
| histone acetyltransferase KAT2A isoform 1 | 4 | 0 | 0 | 4 |
| EWS/FLI fusion protein | 13 | 0 | 0 | 13 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 4 | 0 | 5 |
| Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 10 | 0 | 10 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Sodium-dependent serotonin transporter | 0 | 10 | 1 | 11 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Histamine H1 receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
| Spike glycoprotein | 15 | 0 | 0 | 15 |
| Sodium-dependent dopamine transporter | 0 | 7 | 0 | 7 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Transporter | 0 | 3 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 5 | 0 | 0 | 5 |
| GALC protein | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 10 | 0 | 0 | 10 |
| activating transcription factor 6 | 8 | 0 | 0 | 8 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 6 | 0 | 0 | 6 |
| M-phase phosphoprotein 8 | 7 | 0 | 0 | 7 |
| Fatty acid-binding protein, liver | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor alpha | 0 | 0 | 1 | 1 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 5 | 5 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
| Inositol monophosphatase 1 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 5 | 1 | 6 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 5 | 1 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 5 | 0 | 5 |
| Chain A, Cruzipain | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7 | 0 | 0 | 7 |
| nuclear receptor subfamily 1, group I, member 3 | 18 | 0 | 0 | 18 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| cytochrome P450 2D6 isoform 1 | 5 | 0 | 0 | 5 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 6 | 0 | 6 |
| Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 1 | 1 | 2 |
| Adenosine receptor A2a | 0 | 1 | 1 | 3 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 1 | 6 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1B adrenergic receptor | 0 | 1 | 1 | 2 |
| Alpha-1A adrenergic receptor | 0 | 7 | 1 | 8 |
| Mu-type opioid receptor | 0 | 4 | 0 | 4 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
| Nischarin | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
| Nischarin | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| endonuclease IV | 2 | 0 | 0 | 2 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| GLI family zinc finger 3 | 20 | 0 | 0 | 20 |
| progesterone receptor | 15 | 0 | 0 | 15 |
| retinoid X nuclear receptor alpha | 15 | 0 | 0 | 15 |
| peroxisome proliferator-activated receptor delta | 12 | 0 | 0 | 12 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 12 | 0 | 0 | 12 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 12 | 0 | 0 | 12 |
| atrial natriuretic peptide receptor 1 precursor | 3 | 0 | 0 | 3 |
| heat shock protein beta-1 | 6 | 0 | 0 | 6 |
| Glucocorticoid receptor | 0 | 10 | 1 | 11 |
| Sex hormone-binding globulin | 0 | 0 | 3 | 3 |
| Glycine receptor subunit alpha-1 | 0 | 10 | 0 | 10 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-2 | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-3 | 0 | 10 | 0 | 10 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
| SMAD family member 2 | 7 | 0 | 0 | 7 |
| SMAD family member 3 | 7 | 0 | 0 | 7 |
| Smad3 | 3 | 0 | 0 | 3 |
| farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
| 67.9K protein | 4 | 0 | 0 | 4 |
| aryl hydrocarbon receptor | 11 | 0 | 0 | 11 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 4 | 0 | 0 | 4 |
| Progesterone receptor | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 3 |
| Mu-type opioid receptor | 0 | 8 | 1 | 9 |
| Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
| ORF73 | 0 | 0 | 1 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 8 | 0 | 0 | 8 |
| interleukin 8 | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1 alpha subunit | 9 | 0 | 0 | 9 |
| Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 5 | 0 | 0 | 5 |
| caspase 7, apoptosis-related cysteine protease | 6 | 0 | 0 | 6 |
| caspase-3 | 6 | 0 | 0 | 6 |
| RAD51 | 0 | 1 | 0 | 1 |
| Histone H2A.x | 9 | 0 | 0 | 9 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 8 | 0 | 0 | 8 |
| Glutamate receptor 2 | 8 | 2 | 1 | 11 |
| Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | 0 | 1 | 0 | 1 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| Discoidin domain-containing receptor 2 | 0 | 1 | 1 | 2 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 1 | 2 |
| Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase | 0 | 0 | 1 | 1 |
| glp-1 receptor, partial | 6 | 0 | 0 | 6 |
| Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 4 | 0 | 4 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 5 | 1 | 6 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 3 | 0 | 3 |
| G-protein coupled bile acid receptor 1 | 0 | 0 | 2 | 2 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 3 |
| Steryl-sulfatase | 0 | 0 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 3 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 4 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 5 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 3 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 3 | 0 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 3 | 0 | 3 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Proenkephalin-B | 0 | 0 | 1 | 1 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 4 | 0 | 4 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 1 | 1 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Capsid protein | 0 | 1 | 2 | 3 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 2 | 0 | 2 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
| nuclear receptor coactivator 3 isoform a | 0 | 2 | 0 | 2 |
| Prothrombin | 0 | 0 | 2 | 3 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
| DNA topoisomerase 2-alpha | 0 | 1 | 2 | 8 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
| Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-beta | 0 | 1 | 2 | 9 |
| Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 1 | 2 |
| Glucagon-like peptide 1 receptor | 0 | 0 | 1 | 1 |
| Glucagon-like peptide 1 receptor | 0 | 1 | 1 | 2 |
| Glucagon receptor | 0 | 0 | 1 | 1 |
| Glucagon receptor | 0 | 0 | 1 | 1 |
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
| Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
| Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
| Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
| Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 2 | 0 | 1 | 3 |
| Integrin alpha-IIb | 2 | 0 | 1 | 3 |
| ATP-citrate synthase | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 2 | 1 | 3 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
| Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 1 | 0 | 2 | 1 | 3 |
| Glutamate receptor 2 | 0 | 2 | 1 | 3 |
| Glutamate receptor 3 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 2 | 0 | 2 |
| Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
| Glutamate receptor 4 | 0 | 2 | 1 | 3 |
| Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 4 | 0 | 2 | 0 | 2 |
| Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
| Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
| Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 0 | 2 | 0 | 2 |
| Glutamate racemase | 0 | 0 | 0 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Purine nucleoside phosphorylase | 0 | 2 | 0 | 2 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 2 |
| Ricin | 0 | 1 | 0 | 1 |
| 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | 0 | 0 | 2 | 2 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 2 |
| Shiga toxin subunit A | 0 | 1 | 0 | 1 |
| Guanine deaminase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 15 | 0 | 2 | 0 | 3 |
| Luciferase | 5 | 0 | 0 | 5 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 2 | 3 | 5 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 2 |
| Mast/stem cell growth factor receptor Kit | 0 | 1 | 1 | 2 |
| Breakpoint cluster region protein | 0 | 0 | 2 | 2 |
| Platelet-derived growth factor receptor alpha | 0 | 1 | 1 | 2 |
| Cytochrome P450 3A5 | 0 | 0 | 0 | 1 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 4 | 2 | 6 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
| Gonadotropin-releasing hormone receptor | 0 | 1 | 0 | 1 |
| Gonadotropin-releasing hormone receptor | 0 | 2 | 0 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| WRN | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 4 | 0 | 0 | 4 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
| glucokinase regulatory protein | 2 | 0 | 0 | 2 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 4 |
| Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
| Epidermal growth factor receptor | 0 | 1 | 1 | 2 |
| Plasma kallikrein | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 1 | 2 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 2 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 2 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| SLC16A10 protein | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 2 | 0 | 4 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 2 |
| Monocarboxylate transporter 10 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 2 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 2 | 0 | 0 | 2 |
| ClpP | 2 | 0 | 0 | 2 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
| Aromatase | 0 | 2 | 0 | 2 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 1 | 3 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
| Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
| Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
| Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Dopamine beta-hydroxylase | 0 | 2 | 0 | 2 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 3 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| Lactoperoxidase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 3D | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3C | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
| Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 0 | 1 | 1 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL2 | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase D3 | 0 | 0 | 2 | 2 |
| Luciferin 4-monooxygenase | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase D1 | 0 | 0 | 1 | 1 |
| Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
| PAX8 | 0 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| hemoglobin subunit beta | 1 | 0 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 3 | 0 | 1 | 1 | 2 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Transthyretin | 0 | 1 | 0 | 3 |
| Thyroid hormone receptor alpha | 0 | 2 | 3 | 5 |
| Thyroid hormone receptor beta | 0 | 2 | 3 | 5 |
| Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Bone morphogenetic protein receptor type-1B | 0 | 0 | 1 | 1 |
| Membrane-associated progesterone receptor component 1 | 0 | 0 | 1 | 1 |
| Cell division cycle 7-related protein kinase | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase PLK4 | 0 | 0 | 1 | 1 |
| ATP-dependent RNA helicase DDX3X | 0 | 0 | 1 | 1 |
| Pyridoxal kinase | 0 | 0 | 1 | 1 |
| Citron Rho-interacting kinase | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Chk1 | 0 | 0 | 1 | 1 |
| Aurora kinase A | 0 | 0 | 1 | 1 |
| Cyclin-G-associated kinase | 0 | 0 | 1 | 1 |
| Ephrin type-B receptor 6 | 0 | 0 | 1 | 1 |
| Peroxisomal acyl-coenzyme A oxidase 3 | 0 | 0 | 1 | 1 |
| Receptor-interacting serine/threonine-protein kinase 2 | 0 | 0 | 1 | 1 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | 0 | 0 | 1 | 1 |
| Dynamin-like 120 kDa protein, mitochondrial | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase JAK2 | 0 | 0 | 1 | 1 |
| Eukaryotic translation initiation factor 5B | 0 | 0 | 1 | 1 |
| Rho-associated protein kinase 2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase ULK1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | 0 | 0 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-5 | 0 | 0 | 1 | 1 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | 0 | 0 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-4 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 16 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase-like 5 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 10 | 0 | 0 | 1 | 1 |
| Structural maintenance of chromosomes protein 2 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 6 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase LATS1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase PAK 4 | 0 | 0 | 1 | 1 |
| High affinity nerve growth factor receptor | 0 | 0 | 1 | 1 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 | 0 | 0 | 1 | 1 |
| ADP/ATP translocase 2 | 0 | 0 | 1 | 1 |
| Insulin receptor | 0 | 0 | 1 | 1 |
| Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Fes/Fps | 0 | 0 | 1 | 1 |
| Adenine phosphoribosyltransferase | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Yes | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Lyn | 0 | 0 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 0 | 1 | 1 |
| Insulin-like growth factor 1 receptor | 0 | 0 | 1 | 1 |
| Signal recognition particle receptor subunit alpha | 0 | 0 | 1 | 1 |
| Cytochrome c1, heme protein, mitochondrial | 0 | 0 | 1 | 1 |
| Hepatocyte growth factor receptor | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase HCK | 0 | 0 | 1 | 1 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Fgr | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase A-Raf | 0 | 0 | 1 | 1 |
| Glycogen phosphorylase, brain form | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 0 | 1 | 1 |
| ADP/ATP translocase 3 | 0 | 0 | 1 | 1 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 0 | 1 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 0 | 1 | 1 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase B-raf | 0 | 0 | 1 | 1 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Fer | 0 | 0 | 1 | 1 |
| General transcription and DNA repair factor IIH helicase subunit XPD | 0 | 0 | 1 | 1 |
| Casein kinase II subunit alpha' | 0 | 0 | 1 | 1 |
| Ras-related protein Rab-6A | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 1 | 0 | 0 | 1 | 1 |
| Multifunctional protein ADE2 | 0 | 0 | 1 | 1 |
| Ferrochelatase, mitochondrial | 0 | 0 | 1 | 1 |
| Ribosomal protein S6 kinase beta-1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase JAK1 | 0 | 0 | 1 | 1 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 1 | 1 |
| Probable ATP-dependent RNA helicase DDX6 | 0 | 0 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 3 | 0 | 0 | 1 | 1 |
| Deoxycytidine kinase | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 1 | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 2 | 0 | 0 | 1 | 1 |
| Ephrin type-B receptor 2 | 0 | 0 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TYK2 | 0 | 0 | 1 | 1 |
| UMP-CMP kinase | 0 | 0 | 1 | 1 |
| Phosphatidylethanolamine-binding protein 1 | 0 | 0 | 1 | 1 |
| Wee1-like protein kinase | 0 | 0 | 1 | 1 |
| Heme oxygenase 2 | 0 | 0 | 1 | 1 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 1 | 1 |
| DnaJ homolog subfamily A member 1 | 0 | 0 | 1 | 1 |
| RAC-alpha serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
| RAC-beta serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
| Dual specificity protein kinase TTK | 0 | 0 | 1 | 1 |
| DNA replication licensing factor MCM4 | 0 | 0 | 1 | 1 |
| Myosin-10 | 0 | 0 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 2 | 0 | 1 | 1 | 2 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 0 | 1 | 1 |
| Bone morphogenetic protein receptor type-1A | 0 | 0 | 1 | 1 |
| Activin receptor type-1B | 0 | 0 | 1 | 1 |
| TGF-beta receptor type-1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase receptor R3 | 0 | 0 | 1 | 1 |
| TGF-beta receptor type-2 | 0 | 0 | 1 | 1 |
| Electron transfer flavoprotein subunit beta | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase CSK | 0 | 0 | 1 | 1 |
| Glycine--tRNA ligase | 0 | 0 | 1 | 1 |
| Exosome RNA helicase MTR4 | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase Tec | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase FRK | 0 | 0 | 1 | 1 |
| G protein-coupled receptor kinase 6 | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase SYK | 0 | 0 | 1 | 1 |
| 26S proteasome regulatory subunit 6B | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 8 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 9 | 0 | 0 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 4 | 0 | 0 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 3 | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0 | 0 | 1 | 1 |
| Casein kinase I isoform alpha | 0 | 0 | 1 | 1 |
| Casein kinase I isoform delta | 0 | 0 | 1 | 1 |
| MAP kinase-activated protein kinase 2 | 0 | 0 | 1 | 1 |
| Elongation factor Tu, mitochondrial | 0 | 0 | 1 | 1 |
| Choline-phosphate cytidylyltransferase A | 0 | 0 | 1 | 1 |
| Cysteine--tRNA ligase, cytoplasmic | 0 | 0 | 1 | 1 |
| Casein kinase I isoform epsilon | 0 | 0 | 1 | 1 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | 0 | 0 | 1 | 1 |
| Dual specificity protein kinase CLK1 | 0 | 0 | 1 | 1 |
| Dual specificity protein kinase CLK2 | 0 | 0 | 1 | 1 |
| Dual specificity protein kinase CLK3 | 0 | 0 | 1 | 1 |
| Glycogen synthase kinase-3 alpha | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 7 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 9 | 0 | 0 | 1 | 1 |
| Ras-related protein Rab-27A | 0 | 0 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 1 | 0 | 0 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-3 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Nek2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Nek3 | 0 | 0 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase PLK1 | 0 | 0 | 1 | 1 |
| LIM domain kinase 1 | 0 | 0 | 1 | 1 |
| LIM domain kinase 2 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 0 | 1 | 1 |
| Tyrosine--tRNA ligase, cytoplasmic | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 1 | 1 |
| Ephrin type-B receptor 3 | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 5 | 0 | 0 | 1 | 1 |
| Ephrin type-B receptor 4 | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 4 | 0 | 0 | 1 | 1 |
| Adenylate kinase 2, mitochondrial | 0 | 0 | 1 | 1 |
| Adenosine kinase | 0 | 0 | 1 | 1 |
| Ras-related protein Rab-10 | 0 | 0 | 1 | 1 |
| Actin-related protein 3 | 0 | 0 | 1 | 1 |
| Actin-related protein 2 | 0 | 0 | 1 | 1 |
| GTP-binding nuclear protein Ran | 0 | 0 | 1 | 1 |
| Casein kinase I isoform gamma-2 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 3 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 6 | 0 | 0 | 1 | 1 |
| Cyclin-dependent-like kinase 5 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 16 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 17 | 0 | 0 | 1 | 1 |
| ATP-dependent 6-phosphofructokinase, platelet type | 0 | 0 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 1 | 2 |
| Activin receptor type-1 | 0 | 0 | 1 | 1 |
| Macrophage-stimulating protein receptor | 0 | 0 | 1 | 1 |
| Focal adhesion kinase 1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein kinase BTK | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 18 | 0 | 0 | 1 | 1 |
| Activated CDC42 kinase 1 | 0 | 0 | 1 | 1 |
| Epithelial discoidin domain-containing receptor 1 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 4 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 1 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 5 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 7 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase PAK 2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 3 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 1 | 0 | 0 | 1 | 1 |
| Integrin-linked protein kinase | 0 | 0 | 1 | 1 |
| Rho-associated protein kinase 1 | 0 | 0 | 1 | 1 |
| Non-receptor tyrosine-protein kinase TNK1 | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | 0 | 0 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 1 | 1 |
| Activin receptor type-2B | 0 | 0 | 1 | 1 |
| Bone morphogenetic protein receptor type-2 | 0 | 0 | 1 | 1 |
| Protein-tyrosine kinase 6 | 0 | 0 | 1 | 1 |
| cGMP-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 13 | 0 | 0 | 1 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 0 | 0 | 1 | 1 |
| Protein-tyrosine kinase 2-beta | 0 | 0 | 1 | 1 |
| Maternal embryonic leucine zipper kinase | 0 | 0 | 1 | 1 |
| Structural maintenance of chromosomes protein 1A | 0 | 0 | 1 | 1 |
| Chromodomain-helicase-DNA-binding protein 4 | 0 | 0 | 1 | 1 |
| Peroxisomal acyl-coenzyme A oxidase 1 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 10 | 0 | 0 | 1 | 1 |
| Ephrin type-A receptor 7 | 0 | 0 | 1 | 1 |
| Delta(24)-sterol reductase | 0 | 0 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-1 | 0 | 0 | 1 | 1 |
| Dual specificity testis-specific protein kinase 1 | 0 | 0 | 1 | 1 |
| Myosin light chain kinase, smooth muscle | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 11 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase STK11 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase N1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase N2 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase type IV | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 11 | 0 | 0 | 1 | 1 |
| MAP kinase-activated protein kinase 3 | 0 | 0 | 1 | 1 |
| AP2-associated protein kinase 1 | 0 | 0 | 1 | 1 |
| Myosin light chain kinase 3 | 0 | 0 | 1 | 1 |
| Uncharacterized aarF domain-containing protein kinase 5 | 0 | 0 | 1 | 1 |
| Putative heat shock protein HSP 90-beta 2 | 0 | 0 | 1 | 1 |
| Rab-like protein 3 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase MRCK alpha | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase MRCK gamma | 0 | 0 | 1 | 1 |
| Acyl-CoA dehydrogenase family member 10 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase N3 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase ULK3 | 0 | 0 | 1 | 1 |
| Uncharacterized protein FLJ45252 | 0 | 0 | 1 | 1 |
| Acyl-CoA dehydrogenase family member 11 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase MARK2 | 0 | 0 | 1 | 1 |
| ATP-dependent RNA helicase DHX30 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase TAO1 | 0 | 0 | 1 | 1 |
| STE20-related kinase adapter protein alpha | 0 | 0 | 1 | 1 |
| Myosin-14 | 0 | 0 | 1 | 1 |
| AarF domain-containing protein kinase 1 | 0 | 0 | 1 | 1 |
| ATP-dependent RNA helicase DDX42 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | 0 | 0 | 1 | 1 |
| MAP kinase-activated protein kinase 5 | 0 | 0 | 1 | 1 |
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3B | 0 | 0 | 1 | 1 |
| Misshapen-like kinase 1 | 0 | 0 | 1 | 1 |
| Atypical kinase COQ8A, mitochondrial | 0 | 0 | 1 | 1 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase 15 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Nek9 | 0 | 0 | 1 | 1 |
| ATP-dependent RNA helicase DDX1 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | 0 | 0 | 1 | 1 |
| Aurora kinase B | 0 | 0 | 1 | 1 |
| MAP/microtubule affinity-regulating kinase 4 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase Nek1 | 0 | 0 | 1 | 1 |
| PAS domain-containing serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | 0 | 0 | 1 | 1 |
| EKC/KEOPS complex subunit TP53RK | 0 | 0 | 1 | 1 |
| Dual specificity testis-specific protein kinase 2 | 0 | 0 | 1 | 1 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 5 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 3 | 0 | 0 | 1 | 1 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | 0 | 0 | 1 | 1 |
| Nucleolar GTP-binding protein 1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase D2 | 0 | 0 | 1 | 1 |
| NUAK family SNF1-like kinase 2 | 0 | 0 | 1 | 1 |
| RNA cytidine acetyltransferase | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase SIK2 | 0 | 0 | 1 | 1 |
| STE20-like serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase TAO3 | 0 | 0 | 1 | 1 |
| dCTP pyrophosphatase 1 | 0 | 0 | 1 | 1 |
| Dual specificity protein kinase CLK4 | 0 | 0 | 1 | 1 |
| Casein kinase I isoform gamma-1 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase PAK 6 | 0 | 0 | 1 | 1 |
| Phenylalanine--tRNA ligase beta subunit | 0 | 0 | 1 | 1 |
| Isoleucine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
| BMP-2-inducible protein kinase | 0 | 0 | 1 | 1 |
| Obg-like ATPase 1 | 0 | 0 | 1 | 1 |
| Midasin | 0 | 0 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 4 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 20 | 0 | 0 | 1 | 1 |
| Cyclin-dependent kinase 12 | 0 | 0 | 1 | 1 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase pim-2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 26 | 0 | 0 | 1 | 1 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase NLK | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase TBK1 | 0 | 0 | 1 | 1 |
| Septin-9 | 0 | 0 | 1 | 1 |
| Ribosomal protein S6 kinase alpha-6 | 0 | 0 | 1 | 1 |
| TRAF2 and NCK-interacting protein kinase | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase TAO2 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase ICK | 0 | 0 | 1 | 1 |
| RAC-gamma serine/threonine-protein kinase | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase SIK3 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 2 | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor-associated protein 3 | 0 | 0 | 1 | 1 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | 0 | 0 | 1 | 1 |
| Receptor-interacting serine/threonine-protein kinase 3 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase MRCK beta | 0 | 0 | 1 | 1 |
| Interleukin-1 receptor-associated kinase 3 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase 24 | 0 | 0 | 1 | 1 |
| Casein kinase I isoform gamma-3 | 0 | 0 | 1 | 1 |
| Mitogen-activated protein kinase kinase kinase 4 | 0 | 0 | 1 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |